IEX •
Healthcare •
Biotechnology •
Quote as of 06/23/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization1,754.38 mln
Float205 mln
Earnings Date08/06/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-0.7
Highly suspicious
1-Year Forecast
10.43
Transformational upside
Relative Strength
75
/ 100
Strongly outperforming
Debt / Equity
0.15
Very low leverage
ROE
-14.69
Negative
Business Description
AbCellera Biologics is a Canadian biotechnology company focused on finding and building new antibody-based treatments for patients who currently have few or no good options. The company has two drugs in clinical testing: one aimed at relieving hot flashes and night sweats without using hormones, and another designed to treat immune-related skin conditions like eczema. AbCellera works alongside several major pharmaceutical and investment partners, including Eli Lilly, AbbVie, and Biogen, and operates out of its headquarters in Vancouver, Canada.
